NasalGuard Demand Target healthcare facilities and allergy clinics with NasalGuard products as a drug-free, non-drowsy preventative solution for patients with seasonal allergies, especially in regions with high pollen counts.

Retail Expansion Leverage existing US and UK web stores to partner with regional distributors and retail chains in Europe, Japan, and more UK/US markets to broaden shelf presence and drive cross-border sales.

Private Label Potential Explore white-label or co-branded opportunities for topical nasal gels and related skincare and antiseptic products to expand product portfolio for pharmacies, wellness retailers, and hospital gift shops.

Regulatory Advantage Highlight UK MHRA registrations for NasalGuard AllergieBLOCK and Cold&FluBLOCK to build credibility with European distributors, clinics, and consumer retailers seeking compliant allergy and cold prevention products.

Growth Partnerships Position NasalGuard as a complementary solution for air quality and hygiene-focused brands, enabling strategic partnerships with HVAC, air filtration, and baby/parenting product lines to access new customer segments.